At long last, Sanofi (SNY +1.4%) and Genzyme (GENZ +1.3%) have a deal. Sanofi will pay $74/share...

|About: Sanofi (SNY)|By:, SA News Editor

At long last, Sanofi (SNY +1.4%) and Genzyme (GENZ +1.3%) have a deal. Sanofi will pay $74/share in cash plus a CVR worth as much as $14/share depending on the performance of certain Genzyme drugs. Worth at least $20.1B, it's the second-largest deal in biotech history. (PR)